These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21184993)

  • 1. Meta-analysis of B-type natriuretic peptide's ability to identify stress induced myocardial ischemia.
    Nadir MA; Witham MD; Szwejkowski BR; Struthers AD
    Am J Cardiol; 2011 Mar; 107(5):662-7. PubMed ID: 21184993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome.
    Brown AM; Sease KL; Robey JL; Shofer FS; Hollander JE
    Ann Emerg Med; 2007 Feb; 49(2):153-63. PubMed ID: 17084941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass.
    Feringa HH; Bax JJ; Elhendy A; de Jonge R; Lindemans J; Schouten O; van den Meiracker AH; Boersma E; Schinkel AF; Kertai MD; van Sambeek MR; Poldermans D
    Am J Cardiol; 2006 Jul; 98(1):111-5. PubMed ID: 16784932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of B-type natriuretic peptide in the detection of myocardial ischemia.
    Staub D; Nusbaumer C; Zellweger MJ; Jonas N; Wild D; Pfisterer ME; Mueller-Brand J; Perruchoud AP; Mueller C
    Am Heart J; 2006 Jun; 151(6):1223-30. PubMed ID: 16781223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients.
    Post F; Weilemann LS; Messow CM; Sinning C; Münzel T
    Crit Care Med; 2008 Nov; 36(11):3030-7. PubMed ID: 18824903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percent change in B-type natriuretic peptide levels during treadmill exercise as a screening test for exercise-induced myocardial ischemia.
    Win HK; Chang SM; Raizner M; Shah G; Al Basky F; Desai U; Plana JC; Mahmarian JJ; Quinones MA; Zoghbi WA
    Am Heart J; 2005 Oct; 150(4):695-700. PubMed ID: 16209968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic utility of a single-epitope sandwich B-type natriuretic peptide assay in stable coronary artery disease: data from the Akershus Cardiac Examination (ACE) 1 Study.
    Røsjø H; Tamm NN; Kravdal G; Seferian KR; Høiseth AD; Nygård S; Badr P; Røysland R; Omland T
    Clin Biochem; 2012 Nov; 45(16-17):1269-75. PubMed ID: 22609895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of B-type natriuretic peptide levels with clinical data and exercise testing for predicting coronary artery disease.
    Wolber T; Maeder M; Weilenmann D; Duru F; Bluzaite I; Riesen W; Rickli H; Ammann P
    Am J Cardiol; 2006 Sep; 98(6):764-7. PubMed ID: 16950181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris.
    Weber M; Dill T; Arnold R; Rau M; Ekinci O; Müller KD; Berkovitsch A; Mitrovic V; Hamm C
    Am Heart J; 2004 Oct; 148(4):612-20. PubMed ID: 15459591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining high-sensitivity cardiac troponin and B-type natriuretic peptide in the detection of inducible myocardial ischemia.
    Puelacher C; Wagener M; Honegger U; Assadian M; Schaerli N; Mueller D; Strebel I; Twerenbold R; Boeddinghaus J; Nestelberger T; Wildi K; Sabti Z; Sazgary L; Badertscher P; du Fay de Lavallaz J; Marbot S; Kaiser C; Wild D; Zellweger MJ; Reichlin T; Mueller C
    Clin Biochem; 2018 Feb; 52():33-40. PubMed ID: 29107010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.
    Richards M; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton CM; Crozier IG; Yandle TG; Doughty R; MacMahon S; Sharpe N; ;
    J Am Coll Cardiol; 2006 Jan; 47(1):52-60. PubMed ID: 16386664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery.
    Goei D; Schouten O; Boersma E; Welten GM; Dunkelgrun M; Lindemans J; van Gestel YR; Hoeks SE; Bax JJ; Poldermans D
    Am J Cardiol; 2008 Jan; 101(1):122-6. PubMed ID: 18157978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-type natriuretic peptide and clinical judgment in the detection of exercise-induced myocardial ischemia.
    Lee G; Sou SM; Twerenbold R; Reichlin T; Oshima S; Hochgruber T; Zürcher S; Matter D; Tanglay Y; Freese M; Honegger U; Wild D; Rentsch K; Osswald S; Zellweger MJ; Mueller C
    Am J Med; 2014 May; 127(5):427-35. PubMed ID: 24486287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
    Khan IA; Fink J; Nass C; Chen H; Christenson R; deFilippi CR
    Am J Cardiol; 2006 May; 97(10):1530-4. PubMed ID: 16679099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-type natriuretic peptide testing for structural heart disease screening: a general population-based study.
    Nakamura M; Tanaka F; Sato K; Segawa T; Nagano M
    J Card Fail; 2005 Dec; 11(9):705-12. PubMed ID: 16360967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma N-terminal pro-B-type natriuretic peptide as long-term prognostic marker after major vascular surgery.
    Feringa HH; Schouten O; Dunkelgrun M; Bax JJ; Boersma E; Elhendy A; de Jonge R; Karagiannis SE; Vidakovic R; Poldermans D
    Heart; 2007 Feb; 93(2):226-31. PubMed ID: 16914484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
    Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E
    J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Type B natriuretic peptide (BNP) versus n-terminal type B natriuretic propeptide in the diagnosis of cardiac failure in the elderly over 75 population].
    El Mahmoud R; Alibay Y; Brun-Ney D; Boulard JC; Dubourg O; Puy H; Jondeau G
    Arch Mal Coeur Vaiss; 2006 Mar; 99(3):201-7. PubMed ID: 16618022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ability of B-type natriuretic peptide in predicting postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting.
    Ata Y; Turk T; Ay D; Eris C; Demir M; Ari H; Ata F; Yavuz S; Ozyazicioglu A
    Heart Surg Forum; 2009 Aug; 12(4):E211-6. PubMed ID: 19683991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction.
    Jeong YH; Kim WJ; Park DW; Choi BR; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ
    Int J Cardiol; 2010 May; 141(2):175-81. PubMed ID: 19144424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.